nVerses Capital’s Aehr Test Systems AEHR Stock Holding History

nVerses Capital’s Portfolio AEHR Stock Details AEHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-2,200	Closed	-$24.6K	–	965
2024 Q2	$24.6K	Buy	+2,200	New	+$25.6K	0.01%	750

Other funds holding AEHR

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

OAM

Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return

nVerses Capital's AEHR Position: Q3 2024 in Review

nVerses Capital sold out of Aehr Test Systems (AEHR) in Q3 2024, closing a stake of 2,200 shares — an estimated $24.6K sold.

nVerses Capital first reported a position in AEHR in Q2 2024 and held it in 1 quarter. The position peaked at $24.6K in Q2 2024. 126 funds tracked by Wall St. Rank hold AEHR as of Q3 2024.

nVerses Capital reported no remaining Aehr Test Systems position as of Q3 2024 after selling out during the quarter.
nVerses Capital sold 2,200 Aehr Test Systems shares in Q3 2024, an estimated $24.6K.
nVerses Capital first reported a position in Aehr Test Systems in Q2 2024 and held it in 1 quarter.
nVerses Capital's Aehr Test Systems position peaked at $24.6K in Q2 2024.
126 funds tracked by Wall St. Rank held Aehr Test Systems as of Q3 2024.

Based on nVerses Capital's 13F filing for Q3 2024, filed 16 Oct 2024.